MMWR  Weekly: Current Volume (71)
March 11, 2022 / No. 10
PDF of this issue
:: Interim Estimates of 2021–22 Seasonal Influenza Vaccine Effectiveness — United States, February 2022
:: Characteristics and Adverse Events of Patients for Whom Nifurtimox Was Released Through CDC-Sponsored Investigational New Drug Program for Treatment of Chagas Disease — United States, 2001–2021
:: Evaluation of Serologic Cross-Reactivity Between Dengue Virus and SARS-CoV-2 in Patients with Acute Febrile Illness — United States and Puerto Rico, April 2020–March 2021
::COVID-19 Vaccine Provider Access and Vaccination Coverage Among Children Aged 5–11 Years — United States, November 2021–January 2022
::SARS-CoV-2 Incidence in K–12 School Districts with Mask-Required Versus Mask-Optional Policies — Arkansas, August–October 2021
:: Notes from the Field: Congenital Varicella Syndrome Case — Illinois, 2021